Base Year
Historical Year
Forecast Year
The global chlorpheniramine maleate market size was valued at USD 514.9 million in 2023, driven by the increased prevalence of allergic conditions across the globe. The market is expected to grow at a CAGR of 5.7% during the forecast period of 2024-2032, with the values likely to rise from USD 544.3 million in 2024 to USD 848.1 million by 2032.
Chlorpheniramine maleate, an antihistamine, is commonly used to relieve symptoms like watery eyes, cough, runny nose, and rash from allergies, common cold, and hay fever. The medication manages the symptoms by blocking histamine, a chemical released during an allergic reaction. Heightened public awareness regarding allergy management and the availability of over the counter chlorpheniramine maleate products drives the market demand for the antihistamine.
The rising prevalence of allergic conditions such as allergic rhinitis or seasonal allergies has led to a higher demand for antihistamines like chlorpheniramine maleate. According to recent data, the prevalence of allergic rhinitis is estimated to fall in the range of 5% to 50%, with the incidence rate high in childhood until early adulthood. Further, in the United States, the condition is very common, with population studies suggesting a prevalence of 20-30% in adults and around 40% in children. This increasing prevalence of allergies is expected to bolster chlorpheniramine maleate market growth in the coming years.
In September 2023 , a United States-based pharmaceutical company, Dr. Ferrer Biopharma, shared the results of its product Intranasal Chlorpheniramine Maleate (iCPM) from two randomized controlled trials (ACCROS I and ACCROS III) at the European Respiratory Society (ERS) Congress 2023, revealing the potential of the intranasal chlorpheniramine to treat prolonged post-COVID 19 symptoms. The data from the trials highlighted the antiviral and anti-inflammatory effects of iCPM reduced post-COVID symptoms by over 90% compared to a placebo. This continued research on chlorpheniramine maleate products by the key market players is expected to increase demand and market growth for this medication.
Other factors that influence the chlorpheniramine maleate market value include improvements in healthcare infrastructure, increased access to emerging economies, and the efficacy of the medication to address a wide range of symptoms during an allergic reaction. Moreover, with the rising advancements in formulation technology, new chlorpheniramine maleate products with better efficiency and fewer side effects are anticipated to enter the market.
| Key Trend | Impact |
| Growing Over-the-Counter (OTC) Medication Market | The expansion of the over-the-counter medication market, driven by consumer preference for self-medication and convenience, significantly impacts the chlorpheniramine maleate market demand. As a result, chlorpheniramine maleate products are witnessing increased sales in OTC allergy and cold formulations. Further, the availability of these medications without a prescription attracts a huge consumer base, propelling market growth. |
| Advancements in Drug Formulation | The market is experiencing technological advancements in drug formulation and delivery systems that are likely to accelerate the development of chlorpheniramine maleate products with improved efficacy and reduced side effects. Innovations such as extended-release tablets and combination products are increasingly used to provide symptomatic relief for multiple conditions such as allergies and colds. |
| Robust Network of Distribution Channels | The expansion of distribution channels, including online pharmacies and e-commerce platforms, has made chlorpheniramine maleate more accessible to the growing patient base. This ease of access, along with the convenience of home delivery, is likely to augment the chlorpheniramine maleate market share. However, stringent quality control and regulatory oversight are needed for such distribution platforms to prevent the distribution of substandard products and ensure patient safety. |
| Global Expansion into Emerging Markets | With healthcare infrastructure improving in emerging economies, there is a growing opportunity for chlorpheniramine maleate to expand its footprint. Greater access to medications, healthcare awareness, and rising disposable incomes contribute to higher demand for allergy treatments. Chlorpheniramine maleate, with its established efficacy and affordability, is anticipated to witness high demand in such developing markets. |
Market Breakup by Dosage Form
The market is divided by dosage form into tablets, syrup, eye drops, and injection forms. This market segment offers various options for administration based on patient needs and preferences.
Market Breakup by Application
In terms of application, chlorpheniramine maleate is used to manage symptoms of allergies, common colds, hay fever, and rhinitis, among others. The utility of this market segment is reflected in the use of chlorpheniramine maleate to address a wide range of symptoms associated with these conditions.
Market Breakup by End User
End-users of chlorpheniramine maleate products include hospitals, clinics, and homecare settings, among others. These healthcare facilities provide treatment for allergies and related conditions.
Market Breakup by Distribution Channel
Distribution channels for the chlorpheniramine maleate market includes hospital pharmacies, retail pharmacies, drug stores, and online pharmacies. This diverse network of distribution channels ensures accessibility and convenience for patients to obtain these medications.
Market Breakup by Region
On the basis of region, chlorpheniramine maleate market share includes North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The prevalence of allergies, advancement in the healthcare infrastructure, and the regulatory landscape are some factors that influence the market dynamics in different regional markets. North America leads the market segment which can be attributed to the rising prevalence of allergies and greater accessibility to healthcare services. Further, the robust ongoing research to develop safer and more effective allergy medications led by the key market players is expected to propel the market growth in the region.
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Dosage Form |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market attained a value of about USD 514.9 million in 2023 driven by the increased prevalence of allergic conditions across the globe.
The market is anticipated to grow at a CAGR of 5.70% during the forecast period of 2024-2032, likely to reach a market value of USD 848.1 million by 2032.
The market demand is driven by heightened public awareness regarding allergy management and the availability of over the counter chlorpheniramine maleate products.
One of the significant trends is the continued innovations of chlorpheniramine maleate products by the key market players. In September 2023, a United States-based pharmaceutical company, Dr. Ferrer Biopharma, shared the results of its product Intranasal Chlorpheniramine Maleate (iCPM) to treat prolonged post-COVID 19 symptoms.
Based on the dosage form, the market is segmented into tablets, syrup, eye drops, and injection forms.
Major end users of the market include hospitals, clinics, and homecare settings, among others.
Applications of chlorpheniramine maleate include managing symptoms of allergies, common colds, hay fever, and rhinitis, among others.
Distribution channels for the market include hospital pharmacies, retail pharmacies, drug stores, and online pharmacies.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.
Key players involved in the market are Sun Pharmaceutical Industries Ltd., Novalab Healthcare Pvt. Ltd, Bayer AG, GlaxoSmithKline PLC, Salvidas Pharmaceuticals Pvt. Ltd, Orion Life Science, Viatris Inc., Ataby Pharmaceuticals, Johnson & Johnson, and Zydus Lifesciences Limited.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share